Mitazalimab Uses, Dosage, Side Effects and more

Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).

Trade Name Mitazalimab
Generic Mitazalimab
Mitazalimab Other Names Mitazalimab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share